TGA approved indication for Utrogestan 200 mg, 300 mg and 400 mg (vaginal micronised progesterone)1:
Luteal phase support during assisted reproduction.1
Treatment of threatened miscarriage in women with a history of ≥ 3 previous miscarriages and women with < 3 miscarriages who have a reduced chance of future pregnancy. Benefit of treatment was greatest in women with ≥ 3 previous miscarriages.1
Prevention of preterm birth in women with singleton pregnancy who have a short cervix (midtrimester sonographic cervix ≤25 mm) and/or a history of spontaneous preterm birth.1
Wholesale order numbers
Available to order now. Please contact your preferred supplier directly for their order codes
How to insert Utrogestan
Pharmaceutical particulars
References: 1. Utrogestan (micronised progesterone) Product Information. 2. van der Linden et al. Coch Datab Syst Rev 2015, Issue 7. Art. No.: CD009154. 3. Child T et al. Reprod Med 2018;36:630–45. 4. Devall AJ et al. Cochrane Datab Syst Rev 2021, Issue 4. Art. No.: CD013792. 5. Care A et al. BMJ 2022;376: doi: https://doi.org/10.1136/bmj-2021-064547. 6. The EPPPIC Group. Lancet 2021;397:1183–94. 7. Romero R et al. Am J Obstet Gynaecol 2018;218(2):161-80.
